Sabra Reports Third Quarter 2026 Results; Updates 2026 Guidance
Business Wire•02/11/2026•16:05 ET
0
Key Highlights
- ➤Normalized AFFO $0.41 per diluted share in Q3 2026
- ➤Same-property SHOP Cash NOI increased 14.6% year over year
- ➤2026 Normalized AFFO guidance $1.600-$1.610 per diluted share
- ➤Sabra awarded $425 million of investments at an estimated 7.0% yield
- ➤Annualized cash rent rose to $53 million after 26-property transition
- ➤Quarterly dividend declared at $0.30 per common share
Expert Statements
Rick Matros, CEO and Chair of Sabra Health Care REIT
“Sabra delivered another strong quarter. Same store SHOP Cash NOI margins and REVPOR growth are among the best in the space accompanied by solid occupancy and cash NOI growth. Investment activity continues to be robust, with $425 million currently awarded and more expected to come before year end. We expect our SHOP concentration to be around 40% on a run rate basis by year end 2026 and 50% by the end of 2027. We continue to evaluate our skilled nursing portfolio for optimization opportunities along the lines of our July announcement. Our triple-net skilled nursing and senior housing portfolios again showed increased rent coverage. Leverage ticked down, and we increased our guidance at the midpoint. We do not foresee any barriers that would slow down our current momentum and the shift in our portfolio mix to be more heavily weighted towards SHOP, which will continue to be supported by an exceptionally strong triple-net skilled nursing portfolio.”
Sabra Reports Third Quarter 2026 Results; Updates 2026 Guidance
Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2026.
Get started
Create a free account to read the full story.